As a definitive authority within the healthcare industry, the Global Molecular Diagnostics Market report provides a sweeping evaluation of the dynamics propelling the market. Molecular diagnostics have revolutionized healthcare by providing precise, reliable responses to biological questions. Optimizing strategies for disease management and unlocking the potential for personalized medicine, these tests play an instrumental role in multiple crucial areas within clinical medicine.
Offering a wealth of actionable insights, our report charts the progress of personalized healthcare as driven by the rising demand for molecular diagnostics. These diagnostics have become an imperative tool for monitoring a comprehensive range of health conditions, from infectious diseases to a multitude of chronic illnesses. By employing these effective diagnostic tools, healthcare providers can deliver enhanced patient care and systematically control diseases. Analyzing these strategic measures allows stakeholders to leverage opportunities in the ever-expanding Molecular Diagnostics Market.
The Global Over the Counter (Otc) Drugs Market is Anticipated to Grow at CAGR of 9.86% Through 2026 to Reach USD 274.15 Billion by the End of Forecast Period, 2026.
OTC medications encompass a wide range of drugs designed to alleviate various symptoms such as aches, pains, and itches. By providing relief without the need for a doctor's visit, these medications not only offer cost-effective care but also help alleviate the workload on physicians. OTC drugs contribute to the development of a diverse product portfolio for pharmaceutical companies in the healthcare market. They also facilitate the expansion of product ranges for consumer brands of consumer goods companies. With their widespread availability in pharmacies, OTC medications play a crucial role in promoting accessible healthcare for all.
Key Market Drivers
Rising Prevalence of DiseasesThe growing prevalence of diseases and the use of over the counter (OTC) drugs are key drivers behind the expansion of the OTC drug market. The global incidence of acute and chronic diseases, including cardiovascular, neurological, orthopedic, and respiratory conditions, is witnessing a significant rise. In the United States alone, more than 550,000 individuals are diagnosed with heart failure annually. According to the Centers for Disease Control and Prevention (CDC), approximately 790,000 Americans suffer heart attacks each year, with around 580,000 experiencing their first heart attack and 210,000 facing a recurrent episode.
Risk factors such as diabetes, hypertension, tobacco use, and obesity are contributing to the increasing prevalence of chronic cardiac, neurological, and orthopedic ailments. Consequently, the adoption of OTC medicines has become more prevalent as patients seek effective and convenient treatment options for their chronic conditions. For instance, aspirin is widely utilized to prevent heart attacks, strokes, and other cardiovascular diseases among patients with a history of heart disease or those at high risk. Similarly, ibuprofen and acetaminophen are commonly employed to alleviate pain and inflammation associated with ailments like arthritis, chronic back pain, and headaches. Thus, the growing burden of chronic diseases worldwide is anticipated to drive the demand for OTC drugs, bolstering market growth in the forecast period.
High Cost of Rx Drugs Leading to Shift Towards OTC DrugsThe escalating cost of prescription drugs in recent years has sparked a significant shift in consumer preferences and healthcare strategies, resulting in a notable increase in the demand for over the counter (OTC) drugs. This transformation can be attributed to several key factors. The exorbitant prices of prescription medications have become a formidable burden for many individuals and families, leading them to seek more cost-effective alternatives. The high cost of prescription drugs often forces patients to make difficult choices between necessary medications and other essential expenses, pushing them towards OTC options, which are generally more affordable.
The rise of high-deductible health insurance plans has further incentivized consumers to explore OTC alternatives. With the growing prevalence of these plans, individuals are often responsible for a significant portion of their healthcare expenses out of pocket. Consequently, many are opting for OTC drugs that offer relief for common ailments without the need for expensive doctor visits and prescription copayments.
The increasing availability of information and consumer empowerment through digital platforms and healthcare apps has made it easier for individuals to self-diagnose and self-treat minor health concerns with OTC drugs. This trend empowers patients to take more control of their healthcare decisions and explore accessible, affordable, and convenient OTC options.
Increasing Approval of OTC DrugsThe increasing approval of over the counter (OTC) drugs by regulatory agencies around the world has undoubtedly led to a surge in the demand for these accessible medications. This trend can be attributed to several key factors. The approval of formerly prescription-only medications for OTC use signifies a growing recognition of the safety and efficacy of these drugs when used responsibly and without a doctor's prescription. Regulatory agencies, such as the FDA in the United States, are continuously evaluating the potential for reclassification, allowing more drugs to be available without a prescription. As a result, consumers have a broader range of treatment options for common health issues, from allergies to heartburn and pain relief.
Moreover, the expansion of OTC drug offerings empowers individuals to take greater control of their health and well-being. This approval process enhances consumer access to medications, reducing the need for frequent doctor visits and prescription costs. It also encourages people to proactively address minor health concerns, promoting early intervention and self-care. The convenience and accessibility of OTC drugs further fuel their demand. These products are readily available at local pharmacies, supermarkets, and even online, making them easily accessible to consumers. People appreciate the convenience of purchasing medications when needed, without the delays associated with scheduling doctor appointments and waiting for prescription refills.
The increasing approval of OTC drugs reflects a growing trust in their safety and effectiveness. This trend promotes consumer empowerment and convenience, enabling individuals to make informed choices about their healthcare needs. As more prescription medications become available over the counter, the demand for OTC drugs is likely to continue its upward trajectory, reshaping the landscape of self-care and healthcare access for the better.
Increased Patent Expirations of Many PharmaceuticalsThe increasing number of patent expirations in the pharmaceutical industry has had a significant impact on the demand for over-the-counter (OTC) drugs, leading to a notable shift in consumer preferences and healthcare choices. Several key factors contribute to this trend.
These generic medications are typically more affordable than their brand-name counterparts, making them an attractive option for cost-conscious consumers. As a result, individuals are more likely to choose OTC alternatives for common health issues, such as allergies, pain relief, or acid reflux, where OTC options are readily available and cost-effective. The introduction of generic versions of prescription drugs increases competition within the pharmaceutical industry. This competition drives down prices, not only for generic prescription medications but also for OTC drugs. As consumers become accustomed to the cost savings associated with generic prescriptions, they are more inclined to explore the OTC aisle for other affordable remedies. The increased availability of information and resources online empowers individuals to research and self-diagnose minor health concerns. Armed with knowledge about the active ingredients in OTC drugs, consumers can confidently select OTC products that closely match the effects of prescription medications, especially when generic options are available. The expiration of patents often coincides with marketing efforts by pharmaceutical companies to promote OTC versions of their formerly prescription-only drugs. This marketing push, combined with consumer familiarity with the active ingredient, contributes to increased demand for OTC alternatives.
Key Market Challenges
Price Sensitivity Issues Associated with Over-The-Counter (OTC) DrugsPrice sensitivity issues associated with over-the-counter (OTC) drugs pose challenges to the growth of the OTC drug market. One of the major challenges in the global OTC drug market is price sensitivity. Customers exhibit high sensitivity to prices of OTC medicines as they perceive them to be less essential compared to prescription drugs. Consequently, customers are more inclined to choose cheaper generic drugs or forego treatment altogether. This creates pressure on manufacturers to maintain low prices, impacting profit margins and potentially hindering investment in research and development (R&D). Competitive pricing is another area affected by price sensitivity. With the entry of more players in the market, vendors need to competitively price their products to stay relevant. This often leads to lower prices and narrower profit margins. Consequently, this trend may also contribute to the lack of differentiation between similar OTC products, which can adversely affect market growth. When faced with price competition, vendors are compelled to cut costs, which may have negative implications for product quality and effectiveness. In summary, price sensitivity significantly influences the OTC drug market, constraining its growth and innovation potential during the forecast period.
Inaccurate Self-DiagnosisThe expansion of the global over-the-counter drug industry is expected to face several challenges, including inaccurate self-diagnosis leading to the use of ineffective medications. Instances of pharmaceutical errors and adverse physical effects resulting from over-the-counter cough and cold remedies have been reported. Additionally, drug abuse and addictive behaviors pose further obstacles to market growth.
Individuals who lack knowledge about drugs and medications often consume them without consulting a healthcare professional, which can negatively impact consumer health. Such actions can also pose risks to pharmacies and drug stores, as there have been cases of fatalities due to the ingestion of incorrect pills or medications. Prohibiting the sale of over-the-counter (OTC) medications could help prevent similar incidents. Consequently, during the forecast period, the preservation of human life will act as a constraint on the expansion of the over-the-counter (OTC) medicine industry.
In certain regions, the sale of over-the-counter (OTC) medications is prohibited, requiring adherence to a set of regulations and laws. The Food and Drug Administration (FDA) has established regulations that prohibit the sale of over-the-counter (OTC) medications. Many developed nations have implemented strict restrictions on the sale of over-the-counter (OTC) medicines. Consequently, governmental regulations will present significant obstacles to the over-the-counter (OTC) medicine market during the forecast period.
Key Market Trends
Increasing Geriatric PopulationThe increasing geriatric population is a key trend influencing the over-the-counter drug market growth. The elderly population around the world is increasing year by year. According to the World Health Organization (WHO), by 2050, it is projected to add about 1.5 billion people over the age of 65. This demographic shift is particularly notable in developing countries such as China, India, Japan, Bangladesh, and South Korea, where the elderly population is expected to rise significantly.
Elderly populations face a myriad of health problems, including but not limited to cancer, diabetes, hypertension, and fluctuating blood sugar levels. Managing these health problems often requires regular medication intake. In light of this, older individuals often prefer over-the-counter (OTC) medications for symptom relief, as they provide convenience and accessibility without the need for a prescription. Consequently, the rising geriatric population's inclination towards OTC medications is expected to drive substantial growth in the market during the forecast period.
High Adoption and Acceptance In Developing MarketsThe high adoption and acceptance of over-the-counter (OTC) drugs in developing markets have been instrumental in driving an increase in demand for these accessible medications. Several key factors contribute to this trend. s more individuals migrate to urban centers and gain access to pharmacies and drugstores, the convenience and availability of OTC drugs become increasingly attractive. This convenience factor is pivotal, especially in regions where healthcare infrastructure may still be developing, making OTC drugs an accessible and immediate solution to common health concerns. Moreover, in many developing markets, there is a cultural preference for self-medication and home remedies. OTC drugs align well with these preferences, allowing individuals to address minor health issues independently and without the need for a doctor's visit. This cultural acceptance of self-care further fuels the demand for OTC options.
Additionally, the cost-effectiveness of OTC drugs is a significant driver in developing markets where healthcare expenses can be a considerable burden on households. Many OTC drugs offer a more affordable alternative to prescription medications, making them an attractive choice for individuals seeking relief from common ailments without breaking the bank.
Product InsightsBased on the product, the cold, cough & flu remedies accounted for a significant revenue share in 2022. This dominance can be attributed to seasonal variations, leading to an increase in the occurrence of common colds and coughs among the population. The rise in the senior population, which is more susceptible to cough and colds, coupled with increased automobile pollution, has further contributed to the demand for remedies in this segment. Moreover, the continual growth in research and development activities, along with increasing awareness about advanced medications, is expected to drive the revenue generation of cough remedies in the coming years. The expansion of testing and research facilities, particularly in the pharmaceutical and biotechnology industries, will also play a crucial role in the growth of this segment.
Cold, cough & flu drugs play a vital role in alleviating the symptoms associated with regular colds. These symptoms include a runny nose, sore throat, coughing, and sneezing. According to the Centers for Disease Control and Prevention, cold and cough are the most prevalent illnesses in children under the age of ten and the elderly population over 65. This demographic trend further fuels the demand for effective treatments. The cold, cough & flu remedies segment is expected to experience sustained growth in the market due to various factors contributing to its revenue generation.
Distribution Channel InsightsBased on the distribution channel, the retail pharmacies segment dominated the market with the highest market share during 2022. This is primarily attributed to the rising number of retail pharmacies providing over the counter (OTC) drugs. The convenience and accessibility offered by retail pharmacies have contributed to the growing preference among patients for obtaining medications without a prescription. With an increasing number of retail pharmacies offering a wide range of OTC medications, the drug stores and retail pharmacies category is expected to continue to hold the greatest market share over the projection period.
On the other hand, the e-pharmacies segment is the fastest-growing segment in the over the counter (OTC) drugs market. This growth can be attributed to the significant increase in internet penetration, particularly in developing and underdeveloped regions. Online pharmacies, also known as internet pharmacies or mail-order pharmacies, have gained popularity due to their convenience and ability to deliver orders to consumers through shipping firms, mail services, or online pharmacy web portals. The ease of ordering medications online has attracted a growing number of consumers to opt for e-pharmacies, contributing to their rapid growth in the OTC drugs market.
Regional InsightsAccording to market analysis, the North America segment emerged as the dominant force in the global over the counter (OTC) drugs market in 2022, in terms of revenue, and is projected to maintain its supremacy throughout the forecast period. This can be attributed to the increasing consumer preference for OTC drugs over prescription drugs in the region. The growth of the OTC drugs market in North America is primarily driven by the rising consumption of such drugs. Notably, a National Institute of Health report states that 93% of adults in the U.S. prefer using OTC drugs for minor illnesses before seeking professional help, while 85% of parents prefer the same for their children. Furthermore, the preference for OTC drugs over prescription drugs is also contributing to the growth of the North America OTC drugs market.
Conversely, Europe is predicted to offer the most lucrative opportunities during the forecast period. This projection is based on the widespread practice of self-medication and the presence of numerous OTC drugs manufacturing companies in the region. Additionally, increased public awareness about OTC drugs is fueling market expansion in Europe.
In this report, the Global Over the Counter (OTC) Drugs Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Over the Counter (OTC) Drugs Market, By Product Type:
- Cold & Flu
- Vitamins, Mineral
- & Supplements (VMS)
- Gastrointestinal Products
- Dermatology Products
Over the Counter (OTC) Drugs Market, By Dosage Form:
- Liquids & Solutions
Over the Counter (OTC) Drugs Market, By Route of Administration:
Over the Counter (OTC) Drugs Market, By Distribution Channel:
- Retail Pharmacy
- Hospital Pharmacy
Over the Counter (OTC) Drugs Market, By Region:
- North America
- United States
- United Kingdom
- South Korea
- South America
- Middle East & Africa
- South Africa
- Saudi Arabia
Competitive LandscapeCompany Profiles: Detailed analysis of the major companies present in the Global Over the Counter (OTC) Drugs Market.
Available Customizations:Global Over the Counter (OTC) Drugs market report with the given market data, the publisher offers customizations according to a company's specific needs.
This product will be delivered within 1-3 business days.
What is the estimated value of the Over the Counter (OTC) Drugs Market?
What is the growth rate of the Over the Counter (OTC) Drugs Market?
What is the forecasted size of the Over the Counter (OTC) Drugs Market?
Who are the key companies in the Over the Counter (OTC) Drugs Market?
|No. of Pages||172|
|Forecast Period||2022 - 2028|
| Estimated Market Value ( USD ||$ 186.93 Billion|
| Forecasted Market Value ( USD ||$ 320.98 Billion|
|Compound Annual Growth Rate||9.4%|
Table of Contents
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Cough, Cold & Flu, Vitamins, Mineral, & Supplements (VMS), Analgesics, Gastrointestinal Products, Dermatology Products, Others)
5.2.2. By Dosage Form (Tablets, Capsules, Liquids & Solutions, Cream/Lotion/Ointments, Others)
5.2.3. By Route of Administration (Oral, Parenteral, Topical, Others)
5.2.4. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)
5.2.5. By Region
5.2.6. By Company (2022)
5.3. Market Map
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Dosage Form
6.2.3. By Route Of Administration
6.2.4. By Distribution Channel
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Over the Counter (OTC) Drugs Market Outlook
220.127.116.11. Market Size & Forecast
18.104.22.168.1. By Value
22.214.171.124. Market Share & Forecast
126.96.36.199.1. By Product
188.8.131.52.2. By Dosage Form
184.108.40.206.3. By Route Of Administration
220.127.116.11.4. By Distribution Channel
6.3.2. Canada Over the Counter (OTC) Drugs Market Outlook
18.104.22.168. Market Size & Forecast
22.214.171.124.1. By Value
126.96.36.199. Market Share & Forecast
188.8.131.52.1. By Product
184.108.40.206.2. By Dosage Form
220.127.116.11.3. By Route Of Administration
18.104.22.168.4. By Distribution Channel
6.3.3. Mexico Over the Counter (OTC) Drugs Market Outlook
22.214.171.124. Market Size & Forecast
126.96.36.199.1. By Value
188.8.131.52. Market Share & Forecast
184.108.40.206.1. By Product
220.127.116.11.2. By Dosage Form
18.104.22.168.3. By Route Of Administration
22.214.171.124.4. By Distribution Channel
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Dosage Form
7.2.3. By Route Of Administration
7.2.4. By Distribution Channel
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Over the Counter (OTC) Drugs Market Outlook
126.96.36.199. Market Size & Forecast
188.8.131.52.1. By Value
184.108.40.206. Market Share & Forecast
220.127.116.11.1. By Product
18.104.22.168.2. By Dosage Form
22.214.171.124.3. By Route Of Administration
126.96.36.199.4. By Distribution Channel
7.3.2. United Kingdom Over the Counter (OTC) Drugs Market Outlook
188.8.131.52. Market Size & Forecast
184.108.40.206.1. By Value
220.127.116.11. Market Share & Forecast
18.104.22.168.1. By Product
22.214.171.124.2. By Dosage Form
126.96.36.199.3. By Route Of Administration
188.8.131.52.4. By Distribution Channel
7.3.3. Italy Over the Counter (OTC) Drugs Market Outlook
184.108.40.206. Market Size & Forecast
220.127.116.11.1. By Value
18.104.22.168. Market Share & Forecasty
22.214.171.124.1. By Product
126.96.36.199.2. By Dosage Form
188.8.131.52.3. By Route Of Administration
184.108.40.206.4. By Distribution Channel
7.3.4. France Over the Counter (OTC) Drugs Market Outlook
220.127.116.11. Market Size & Forecast
18.104.22.168.1. By Value
22.214.171.124. Market Share & Forecast
126.96.36.199.1. By Product
188.8.131.52.2. By Dosage Form
184.108.40.206.3. By Route Of Administration
220.127.116.11.4. By Distribution Channel
7.3.5. Spain Over the Counter (OTC) Drugs Market Outlook
18.104.22.168. Market Size & Forecast
22.214.171.124.1. By Value
126.96.36.199. Market Share & Forecast
188.8.131.52.1. By Product
184.108.40.206.2. By Dosage Form
220.127.116.11.3. By Route Of Administration
18.104.22.168.4. By Distribution Channel
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Dosage Form
8.2.3. By Route Of Administration
8.2.4. By Distribution Channel
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Over the Counter (OTC) Drugs Market Outlook
22.214.171.124. Market Size & Forecast
126.96.36.199.1. By Value
188.8.131.52. Market Share & Forecast
184.108.40.206.1. By Product
220.127.116.11.2. By Dosage Form
18.104.22.168.3. By Route Of Administration
22.214.171.124.4. By Distribution Channel
8.3.2. India Over the Counter (OTC) Drugs Market Outlook
126.96.36.199. Market Size & Forecast
188.8.131.52.1. By Value
184.108.40.206. Market Share & Forecast
220.127.116.11.1. By Product
18.104.22.168.2. By Dosage Form
22.214.171.124.3. By Route Of Administration
126.96.36.199.4. By Distribution Channel
8.3.3. Japan Over the Counter (OTC) Drugs Market Outlook
188.8.131.52. Market Size & Forecast
184.108.40.206.1. By Value
220.127.116.11. Market Share & Forecast
18.104.22.168.1. By Product
22.214.171.124.2. By Dosage Form
126.96.36.199.3. By Route Of Administration
188.8.131.52.4. By Distribution Channel
8.3.4. South Korea Over the Counter (OTC) Drugs Market Outlook
184.108.40.206. Market Size & Forecast
220.127.116.11.1. By Value
18.104.22.168. Market Share & Forecast
22.214.171.124.1. By Product
126.96.36.199.2. By Dosage Form
188.8.131.52.3. By Route Of Administration
184.108.40.206.4. By Distribution Channel
8.3.5. Australia Over the Counter (OTC) Drugs Market Outlook
220.127.116.11. Market Size & Forecast
18.104.22.168.1. By Value
22.214.171.124. Market Share & Forecast
126.96.36.199.1. By Product
188.8.131.52.2. By Dosage Form
184.108.40.206.3. By Route Of Administration
220.127.116.11.4. By Distribution Channel
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Dosage Form
9.2.3. By Route Of Administration
9.2.4. By Distribution Channel
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Over the Counter (OTC) Drugs Market Outlook
18.104.22.168. Market Size & Forecast
22.214.171.124.1. By Value
126.96.36.199. Market Share & Forecast
188.8.131.52.1. By Product
184.108.40.206.2. By Dosage Form
220.127.116.11.3. By Route Of Administration
18.104.22.168.4. By Distribution Channel
9.3.2. Argentina Over the Counter (OTC) Drugs Market Outlook
22.214.171.124. Market Size & Forecast
126.96.36.199.1. By Value
188.8.131.52. Market Share & Forecast
184.108.40.206.1. By Product
220.127.116.11.2. By Dosage Form
18.104.22.168.3. By Route Of Administration
22.214.171.124.4. By Distribution Channel
9.3.3. Colombia Over the Counter (OTC) Drugs Market Outlook
126.96.36.199. Market Size & Forecast
188.8.131.52.1. By Value
184.108.40.206. Market Share & Forecast
220.127.116.11.1. By Product
18.104.22.168.2. By Dosage Form
22.214.171.124.3. By Route Of Administration
126.96.36.199.4. By Distribution Channel
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Dosage Form
10.2.3. By Route Of Administration
10.2.4. By Distribution Channel
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Over the Counter (OTC) Drugs Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Dosage Form
10.3.1.2.3. By Route Of Administration
10.3.1.2.4. By Distribution Channel
10.3.2. Saudi Arabia Over the Counter (OTC) Drugs Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Dosage Form
10.3.2.2.3. By Route Of Administration
10.3.2.2.4. By Distribution Channel
10.3.3. UAE Over the Counter (OTC) Drugs Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Dosage Form
10.3.3.2.3. By Route Of Administration
10.3.3.2.4. By Distribution Channel
12.2. Mergers & Acquisitions
12.3. Product Launches
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15.2. Service Offerings
15.3. Recent Developments
15.4. Key Personnel
15.5. SWOT Analysis
15.5.1. Sanofi S.A.
15.5.2. Pfizer Inc.
15.5.3. GlaxoSmithKline plc
15.5.4. Perrigo Company plc
15.5.5. Reckitt Benckiser Group PLC
15.5.6. Takeda Pharmaceutical Company Ltd
15.5.7. Boehringer Ingelheim International GmbH
15.5.8. Sun Pharmaceutical Industries Ltd.
15.5.9. Teva Pharmaceutical Industries Ltd.
15.5.10. Glenmark Pharmaceuticals Ltd.
A selection of companies mentioned in this report includes:
- Sanofi S.A.
- Pfizer Inc.
- GlaxoSmithKline plc
- Perrigo Company plc
- Reckitt Benckiser Group PLC
- Takeda Pharmaceutical Company Ltd
- Boehringer Ingelheim International GmbH
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Glenmark Pharmaceuticals Ltd.